A NEW diabetes drug launched in Bahrain assures patients of lower risk of a drop in blood sugar during the night.
Tresiba, rolled out in five GCC markets including Bahrain, Qatar, Oman, Kuwait and Saudi Arabia, was approved by the US Food and Drug Administration (FDA) last September (2015) .